About Delcath
Delcath is a development-stage, specialty pharmaceutical and medical device company focused on oncology. We’re researching breakthroughs in regional chemotherapies with the goal of improving clinical outcomes and potentially reducing drug-related adverse events.
History
Delcath has spent many years researching ways to administer ultra-high doses of established chemotherapeutic drugs to the liver.
Management Team
Meet the Rest of the Management Team
Medical Advisory Board
Meet the Rest of the Medical Advisory Board